Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 13 studies | 22% ± 6% | |
CD4-positive, alpha-beta T cell | 10 studies | 19% ± 3% | |
macrophage | 9 studies | 20% ± 3% | |
CD8-positive, alpha-beta T cell | 8 studies | 21% ± 8% | |
T cell | 7 studies | 19% ± 3% | |
epithelial cell of proximal tubule | 7 studies | 21% ± 5% | |
ciliated cell | 7 studies | 28% ± 10% | |
epithelial cell | 5 studies | 31% ± 15% | |
fibroblast | 4 studies | 20% ± 5% | |
astrocyte | 4 studies | 25% ± 8% | |
enterocyte | 4 studies | 19% ± 3% | |
CD4-positive, alpha-beta memory T cell | 4 studies | 20% ± 3% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 4% | |
exhausted T cell | 3 studies | 31% ± 8% | |
myeloid cell | 3 studies | 33% ± 12% | |
effector CD4-positive, alpha-beta T cell | 3 studies | 22% ± 1% | |
type II pneumocyte | 3 studies | 17% ± 2% | |
type I pneumocyte | 3 studies | 22% ± 6% | |
transit amplifying cell | 3 studies | 21% ± 4% | |
endothelial cell | 3 studies | 16% ± 1% | |
hepatocyte | 3 studies | 36% ± 12% | |
gamma-delta T cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3829.29 | 89 / 89 | 100% | 64.69 | 901 / 901 |
stomach | 100% | 771.27 | 359 / 359 | 100% | 60.47 | 286 / 286 |
intestine | 100% | 1985.88 | 966 / 966 | 100% | 61.42 | 525 / 527 |
ovary | 100% | 1118.60 | 180 / 180 | 100% | 34.27 | 428 / 430 |
liver | 100% | 2657.55 | 226 / 226 | 100% | 74.10 | 404 / 406 |
thymus | 100% | 1216.38 | 653 / 653 | 99% | 48.42 | 600 / 605 |
lung | 100% | 1198.83 | 578 / 578 | 96% | 44.44 | 1104 / 1155 |
bladder | 100% | 1087.57 | 21 / 21 | 95% | 45.89 | 481 / 504 |
pancreas | 99% | 716.91 | 326 / 328 | 95% | 40.75 | 169 / 178 |
breast | 100% | 887.69 | 459 / 459 | 90% | 27.39 | 1007 / 1118 |
prostate | 99% | 1308.82 | 243 / 245 | 89% | 31.10 | 448 / 502 |
uterus | 100% | 929.36 | 170 / 170 | 88% | 35.28 | 403 / 459 |
skin | 94% | 449.63 | 1694 / 1809 | 85% | 33.58 | 399 / 472 |
esophagus | 97% | 571.74 | 1398 / 1445 | 73% | 30.72 | 134 / 183 |
adrenal gland | 100% | 10056.62 | 258 / 258 | 43% | 32.40 | 99 / 230 |
brain | 71% | 232.47 | 1876 / 2642 | 65% | 12.14 | 457 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.43 | 29 / 29 |
spleen | 100% | 732.42 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 63.19 | 1 / 1 |
blood vessel | 100% | 1155.31 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1025.73 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 96% | 544.09 | 774 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 44.80 | 77 / 80 |
heart | 95% | 856.14 | 819 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 590.02 | 828 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 15.47 | 34 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0033499 | Biological process | galactose catabolic process via UDP-galactose |
GO_0006006 | Biological process | glucose metabolic process |
GO_0006012 | Biological process | galactose metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0004034 | Molecular function | aldose 1-epimerase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0030246 | Molecular function | carbohydrate binding |
Gene name | GALM |
Protein name | Galactose mutarotase (EC 5.1.3.3) (Aldose 1-epimerase) Galactose mutarotase (Aldose 1-epimerase) |
Synonyms | BLOCK25 |
Description | FUNCTION: Mutarotase that catalyzes the interconversion of beta-D-galactose and alpha-D-galactose during galactose metabolism . Beta-D-galactose is metabolized in the liver into glucose 1-phosphate, the primary metabolic fuel, by the action of four enzymes that constitute the Leloir pathway: GALM, GALK1 (galactokinase), GALT (galactose-1-phosphate uridylyltransferase) and GALE (UDP-galactose-4'-epimerase) . Involved in the maintenance of the equilibrium between the beta- and alpha-anomers of galactose, therefore ensuring a sufficient supply of the alpha-anomer for GALK1 . Also active on D-glucose although shows a preference for galactose over glucose . . |
Accessions | B8ZZ75 H7C320 ENST00000410063.5 ENST00000444351.5 H7C1B5 Q96C23 ENST00000434934.1 ENST00000272252.10 |